The interplay between ras oncogenes and tumor suppressor genes in experimental carcinogenesis.
Balmain
A
A
Beatson Institute for Cancer Research, Glasgow, Scotland.
Brown
K
K
Bremner
R
R
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D002872:Chromosome Deletion; D019204:GTP-Binding Proteins / Q000235:genetics / Q000502:physiology*; D020690:GTPase-Activating Proteins; D016147:Genes, Tumor Suppressor; D011905:Genes, ras; D051379:Mice; D005810:Multigene Family; D009153:Mutagens / Q000494:pharmacology; D009374:Neoplasms, Experimental / Q000235:genetics*; D015689:Oncogene Protein p21(ras) / Q000235:genetics / Q000502:physiology*; D009928:Organ Specificity; D011506:Proteins / Q000235:genetics / Q000502:physiology*; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics / Q000502:physiology*; D020703:ras GTPase-Activating Proteins
D020690:GTPase-Activating Proteins; D009153:Mutagens; D011506:Proteins; D020703:ras GTPase-Activating Proteins; D019204:GTP-Binding Proteins; D015689:Oncogene Protein p21(ras); D016283:Proto-Oncogene Proteins p21(ras)